Biomineralization Precursor Carrier System Based on Carboxyl-Functionalized Large Pore Mesoporous Silica Nanoparticles

Abstract

Bone and teeth are derived from intrafibrillarly mineralized collagen fibrils as the second level of hierarchy. According to polymer-induced liquid-precursor process, using amorphous calcium phosphate precursor (ACP) is able to achieve intrafibrillar mineralization in the case of bone biomineral in vitro. Therefore, ACP precursors might be blended with any osteoconductive scaffold as a promising bone formation supplement for in-situ remineralization of collagens in bone. In this study, mesoporous silica nanoparticles with carboxyl-functionalized groups and ultra large-pores have been synthesized and used for the delivery of liquid like biomimetic precursors (ACP). The precursor delivery capacity of the nanoparticles was verified by the precursor release profile and successful mineralization of 2D and 3D collagen models. The nanoparticles could be completely degraded in 60 days and exhibited good biocompatibility as well. The successful translational strategy for biomineralization precursors showed that biomineralization precursor laden ultra large pore mesoporous silica possessed the potential as a versatile supplement in demineralized bone formation through the induction of intrafibrillar collagen mineralization.

Keywords

biomineralization / mesoporous silica / amorphous calcium phosphate / biocompatibility / biodegradability / carboxyl functionalization

References

[1] Ferreira AM, Gentile P, Chiono V, et al. Collagen for bone tissue regeneration. Acta Biomate, 2018(9):3191–3200

[2] WeinerS, WagnerHD. The material bone: structure-mechanical function relations. Annu Rev Mater Sci, 1998, 28(1): 271-298

[3] OlsztaMJ, ChengX, JeeSS, et al.. Bone structure and formation: A new perspective. Mat Sci Eng R, 2007, 58(3–5): 77-116

[4] JiaoK, NiuLN, MaCF, et al.. Collagen Mineralization: Complementarity and Uncertainty in Intrafibrillar Mineralization of Collagen. Adv Funct Mater, 2016, 26(38): 6850-6850

[5] NudelmanF, PieterseK, GeorgeA, et al.. The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater, 2010, 9(12): 1004

[6] LiuY, LuoD, WangT. Hierarchical structures of bone and bioinspired bone tissue engineering. Small, 2016, 12(34): 4611-4632

[7] MahamidJ, SharirA, AddadiL, et al.. Amorphous calcium phosphate is a major component of the forming fin bones of zebrafish: Indications for an amorphous precursor phase. P Natl Acad Sci USA, 2008, 105(35): 12 748-12 753

[8] ShieldsLB, RaqueGH, GlassmanSD, et al.. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976), 2006, 31(5): 542-547

[9] LiuY, LiuS, LuoD, et al.. Hierarchically staggered nanostructure of mineralized collagen as a bone-grafting scaffold. Adv Mater, 2016, 28(39): 8740-8748

[10] LuoXJ, YangHY, NiuLN, et al.. Translation of a solution-based biomineralization concept into a carrier-based delivery system via the use of expanded-pore mesoporous silica. Acta Biomater, 2016, 31: 378-387

[11] ZhangW, LuoXJ, NiuLN, et al.. Biomimetic intrafibrillar mineralization of type I collagen with intermediate precursors-loaded mesoporous carriers. Sci Rep, 2015, 5: 11 199

[12] TangFQ, LiLL, ChenD. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater, 2012, 24(12): 1504-1534

[13] YangYN, YuCZ. Advances in silica based nanoparticles for targeted cancer therapy. Nanomed Nanotechnol Biol Med, 2016, 12(2): 317-332

[14] DaiCL, GuoH, LuJX, et al.. Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based µCT. Biomaterials, 2011, 32(33): 8506-8517

[15] KneževićN, DurandJO. Large pore mesoporous silica nanomaterials for application in delivery of biomolecules. Nanoscale, 2015, 7(6): 2199-2209

[16] Mizutani M, Yamada Y, Yano K. Pore-expansion of monodisperse mesoporous silica spheres by a novel surfactant exchange method. Chem Commun, 2007, (11):1172–1174

[17] SlowingII, WuCW, ViveroE J, et al.. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small, 2009, 5(1): 57-62

[18] YangQ, WangSC, FanPW, et al.. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem Mater, 2005, 17(24): 5999-6003

[19] KimMH, NaHK, KimYK, et al.. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano, 2011, 5(5): 3568-3576

[20] MuhammadF, GuoMY, QiWX, et al.. pH-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J Am Chem Soc, 2011, 133(23): 8778-8781

[21] LuoZ, CaiKY, HuY, et al.. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. Angew Chem Int Ed, 2011, 50(3): 640-643

[22] BahadurNM, FurusawaT, SatoM, et al.. Fast and facile synthesis of silica coated silver nanoparticles by microwave irradiation. J Colloid Interface Sci, 2011, 355(2): 312-320

[23] AnY, ChenM, XueQ, et al.. Preparation and self-assembly of carboxylic acid-functionalized silica. J Colloid Interface Sci, 2007, 311(2): 507-513

[24] ManzanoM, AinaV, AreanC, et al.. Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. Chem Eng J, 2008, 137(1): 30-37

[25] MouslmaniM, RosenholmJM, PrabhakarN, et al.. Curcumin associated poly (allylamine hydrochloride)-phosphate self-assembled hierarchically ordered nanocapsules: size dependent investigation on release and DPPH scavenging activity of curcumin. RSC Advances, 2015, 5(24): 18 740-18 750

[26] NiuLN, JeeSE, JiaoK, et al.. Collagen intrafibrillar mineralization as a result of the balance between osmotic equilibrium and electroneutrality. Nat Mater, 2017, 16(3): 370

[27] ZhangYZ, ZhiZZ, JiangTY, et al.. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release, 2010, 145(3): 257-263

[28] ZhangQ, WangX, LiPZ, et al.. Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer-targeted drug delivery in vivo. Adv Funct Mater, 2014, 24(17): 2450-2461

[29] LinYS, HaynesCL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc, 2010, 132(13): 4834-4842

[30] HudsonSP, PaderaRF, LangerR, et al.. The biocompatibility of mesoporous silicates. Biomaterials, 2008, 29(30): 4045-4055

[31] YangK, MaYQ. Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat Nanotechnol, 2010, 5(8): 579

[32] ZhaoY, SunX, ZhangG, et al.. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano, 2011, 5(2): 1366-1375

[33] SourisJS, LeeCH, ChengSH, et al.. Surface chargemediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials, 2010, 31(21): 5564-5574

[34] ChangBS, GuoJ, LiuCY, et al.. Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem, 2010, 20(44): 9941-9947

[35] ZhouXJ, FengW, QiuKX, et al.. BMP-2 derived peptide and dexamethasone incorporated mesoporous silica nanoparticles for enhanced osteogenic differentiation of bone mesenchymal stem cells. ACS Appli Mater Inter, 2015, 7(29): 15 777-15 789

[36] FuchsAK, SyrovetsT, HaasKA, et al.. Carboxyl-and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets. Biomaterials, 2016, 85: 78-87

[37] ZhouMY, DuX, LiWK, et al.. One-pot synthesis of redox-triggered biodegradable hybrid nanocapsules with a disulfide-bridged silsesquioxane framework for promising drug delivery. J Mater Chem B, 2017, 5(23): 4455-4469

[38] CroissantJG, FatieievY, KhashabNM. Degradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticles. Adv Mater, 2017, 29(9): 1604 634

[39] ShadjouN, HasanzadehM. Bone tissue engineering using silica-based mesoporous nanobiomaterials: Recent progress. Mater Sci Eng C, 2015, 55: 401-409

[40] MöllerK, BeinT. Talented mesoporous silica nanoparticles. Chem Mater, 2016, 29(1): 371-388

[41] GodinB, GuJ, SerdaRE, et al.. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J Biomed Mater Research A, 2010, 94(4): 1236-1243

[42] YangHY, NiuLN, SunJL, et al.. Biodegradable mesoporous delivery system for biomineralization precursors. Int J Nanomed, 2017, 12: 839

[43] WingenderB, BradleyP, SaxenaN, et al.. Biomimetic organization of collagen matrices to template bone-like microstructures. Matrix Biol, 2016, 52: 384-396